Regulatory Blog

The Regulatory News you Need to Know,Share & Grow

Apr 272 min read

USFDA Guidance: Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products Q&A

On 24 April 2026 (Wednesday) the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research released a...

Jun 27, 20231 min read

USFDA Guidance: Risk & Efficacy Information in Direct-to Consumer Prescription Drug Promo Labeling

A final guidance for the industry was issued today (27 June, 2023) by the US Food and Drug Administration titled "Presenting Quantitative...